Role of VLDL/chylomicron in amyloid formation in familial amyloidotic polyneuropathy

被引:19
作者
Sun, XG
Ando, Y
Haraoka, K
Katsuragi, S
Yamashita, T
Yamashita, S
Okajima, M
Terazaki, H
Okabe, H
机构
[1] Kumamoto Univ, Grad Sch Med Sci, Dept Diagnost Med, Kumamoto 8600811, Japan
[2] Kumamoto Univ, Grad Sch Med Sci, Dept Gastroenterol & Hepatol, Kumamoto 8600811, Japan
[3] Kituti Natl Hosp, Dept Psychiat, Koushi 8611116, Japan
[4] Kumamoto Univ, Grad Sch Med Sci, Dept Neurol, Kumamoto 8600811, Japan
关键词
transthyretin; FAP; lipoprotein; chylomicron; amyloid;
D O I
10.1016/j.bbrc.2003.10.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We examined the affinity of transthyretin (TTR) for lipoproteins and the effect of lipoproteins on TTR-related amyloidogenesis using serum samples from healthy volunteers and patients with familial amyloidotic polyneuropathy (FAP) ATTRVa130Met. In both volunteers and patients, TTR levels were highest in the VLDL fraction containing chylomicrons (VLDL/CM) and next highest in the HDL fraction. Levels were lowest in the LDL fraction. Mass spectrometric analyses of TTR spectra revealed significant TTR association with VLDL/CM and the levels of variant TTR were decreased in the FAP patients. Examination of the affinity of wildtype and variant TTRs for lipoprotein via a quartz crystal microbalance (QCM) revealed the highest affinity of both proteins for VLDL/CM. In in vitro amyloid formation test measured with thioflavin T and electron microscopy, in the presence of VLDL/CM, amyloid formation of TTR was enhanced more than in the presence LDL or in the absence of lipoprotein species. These results suggest that TTR should be highly associated especially with VLDL/CM and amyloidogenicity of TTR should be enhanced around the adipocytes. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:344 / 350
页数:7
相关论文
共 41 条
[1]   TRANSTHYRETIN AND FAMILIAL AMYLOIDOTIC POLYNEUROPATHY [J].
ANDO, Y ;
ARAKI, S ;
ANDO, M .
INTERNAL MEDICINE, 1993, 32 (12) :920-920
[2]   LOW PLASMA APOLIPOPROTEIN AII LEVELS IN HUMAN AND MOUSE AMYLOIDOSIS WITH MUTANT TRANSTHYRETIN (MET-30) GENE [J].
ANDO, Y ;
TANAKA, Y ;
UEYAMA, H ;
SAKASHITA, N ;
YONEHARA, T ;
HIGUCHI, K ;
ARAKI, S .
ANNALS OF NEUROLOGY, 1993, 33 (01) :101-103
[3]   Down regulation of a harmful variant protein by replacement of its normal protein [J].
Ando, Y ;
Yamashita, T ;
Nakamura, M ;
Tanaka, Y ;
Hashimoto, M ;
Tashima, K ;
Suhr, O ;
Uemura, Y ;
Obayashi, K ;
Terazaki, H ;
Suga, M ;
Uchino, M ;
Ando, M .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1997, 1362 (01) :39-46
[4]   A new simple and rapid screening method for variant transthyretin-related amyloidosis [J].
Ando, Y ;
Ohlsson, PI ;
Suhr, O ;
Nyhlin, N ;
Yamashita, T ;
Holmgren, G ;
Danielsson, A ;
Sandgren, O ;
Uchino, M ;
Ando, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 228 (02) :480-483
[5]   TYPE-I FAMILIAL AMYLOIDOTIC POLYNEUROPATHY (JAPANESE TYPE) [J].
ARAKI, S .
BRAIN & DEVELOPMENT, 1984, 6 (02) :128-133
[6]   IN-SITU CHARACTERIZATION OF LANGMUIR-BLODGETT-FILMS DURING A TRANSFER PROCESS - EVALUATION OF TRANSFER RATIO AND WATER INCORPORATION BY USING A QUARTZ-CRYSTAL MICROBALANCE [J].
ARIGA, K ;
OKAHATA, Y .
LANGMUIR, 1994, 10 (09) :3255-3259
[7]  
BOOMSMA F, 1991, J PHARMACOL EXP THER, V259, P551
[8]   Hepatic familial amyloidosis caused by a new mutation in the apolipoprotein AI gene:: Clinical and pathological features [J].
Caballería, J ;
Bruguera, M ;
Solé, M ;
Campistol, JM ;
Rodés, J .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2001, 96 (06) :1872-1876
[9]   Apolipoprotein Al and transthyretin as components of amyloid fibrils in a kindred with apoAl Leu178His amyloidosis [J].
de Sousa, MM ;
Vital, C ;
Ostler, D ;
Fernandes, R ;
Pouget-Abadie, J ;
Carles, D ;
Saraiva, MJ .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (06) :1911-1917
[10]   PROTEIN-BINDING AND STABILITY OF NOREPINEPHRINE IN HUMAN-BLOOD PLASMA - INVOLVEMENT OF PREALBUMIN, ALPHA-1-ACID GLYCOPROTEIN AND ALBUMIN [J].
DEVERA, N ;
CRISTOFOL, RM ;
FARRE, ER .
LIFE SCIENCES, 1988, 43 (16) :1277-1286